Saving Human Lives

One At a Time

Developing innovative life-saving therapies to patients

Clinical Pipeline

Clinical Pipeline

One deep-rooted belief we hold here at Enzychem Lifesciences is that any form of treatment should be accessible to patients all over the world. As we pursue to develop a global new drug, our team carries the important duty of ensuring EC-18’s efficacy backed up by comprehensive studies. Enzychem has commenced clinical trials in 2016, and since then, we have been conducting ongoing research in the drug’s effects on patients with one of various conditions.

Read More
Clinical Program

Clinical Program

The global drug development program at Enzychem entails an extensive sequence of clinical studies on the safety and efficacy of EC-18 in various indications.

Read More

Latest News

December 12, 2019 Enzychem Lifesciences Presents EC-18 NASH Development Update at The Liver Meeting 2019 Read More
December 12, 2019 Enzychem Lifesciences Announces Poster Presentation at Liver Meeting 2019 Read More
October 16, 2019 Enzychem Lifesciences Announces Three Abstracts Accepted at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Read More
March 27, 2019 Enzychem Lifesciences Announces Poster Presentations at the AACR 2019 Annual Meeting Read More